Group One Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Group One Trading’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,900	Closed	-$8.37K	–	8977
2025 Q2	$8.37K	Sell	7,900 -3,900	-33%	-$3.83K	﹤0.01%	6824
2025 Q1	$12.9K	Hold	11,800	–	–	﹤0.01%	6103
2024 Q4	$17.8K	Sell	11,800 -100	-0.8%	-$158	﹤0.01%	5767
2024 Q3	$17.7K	Sell	11,900 -100	-0.8%	-$155	﹤0.01%	5290
2024 Q2	$19.4K	Hold	12,000	–	–	﹤0.01%	5254
2024 Q1	$20.4K	Buy	+12,000	New	+$22.4K	﹤0.01%	5396
2023 Q4	–	Sell	-900	Closed	-$5.53K	–	8012
2023 Q3	$5.53K	Buy	+900	New	+$6.19K	﹤0.01%	6652
2022 Q3	–	Sell	-4,600	Closed	-$66K	–	8073
2022 Q2	$66K	Buy	+4,600	New	+$66.9K	﹤0.01%	5332

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Group One Trading's PMVP Position: Q1 2026 in Review

Group One Trading opened a new position in PMV Pharmaceuticals (PMVP) in Q1 2026: 90 shares worth $112. The stake represents ﹤0.01% of the portfolio and ranks #7423 among its holdings. This is a return to the name: Group One Trading previously reported a position in PMVP as recently as Q2 2025.

Group One Trading first reported a position in PMVP in Q4 2022 and has held it in 12 quarters since. The position peaked at $72.7K in Q3 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

Group One Trading held 90 shares of PMV Pharmaceuticals worth $112 as of Q1 2026.
PMV Pharmaceuticals was a new Group One Trading position in Q1 2026.
PMV Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7423 holding.
Group One Trading first reported a position in PMV Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
Group One Trading's PMV Pharmaceuticals position peaked at $72.7K in Q3 2023.
69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.